Myths and misconceptions about insulin initiation among diabetics in a rural health sector of southern India

 

S B Jaikar^1*, R Sharvegar²

 

 

REFERENCES

1. Joshi SR, Parikh RM. India – Diabetes Capital of the World: Now heading towards Hypertension. J Assoc Physicians India 2007; 55:323–324. 3. Lind L, Berne C, Lithell H. Prevalence.
2. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, et al. (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35: 1364-1379
3. Caballero AE (2007) Improving diabetes care and education of Latinos: a challenging but important mission. Curr Diab Rep 7: 321-323.
4. Caballero AE1 (2011) Understanding the Hispanic/Latino patient. Am J Med 124: S10-15.
5. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853.
6. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986
7. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, et al. (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1diabetes. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group N Engl J Med 353: 2643.
8. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow up of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589.
9. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C (2005) Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 28: 600-606.
10. Siminerio L (2006) Challenges and strategies for moving patients to injectable medications. Diabetes Educ 32 Suppl 2: 82S-90S.
11. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, et al. (2005) Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 28: 2673-2679.
12. Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999; 46: 239–246.
13. U. S. Ahmed, B. Junaidi, A. W. Ali, O. Akhter, M. Salahuddin and J. Akhter. Treatment Barriers in initiating insulin therapy in a South Asian Muslim community. Diabet. Med. 27, 169–174 (2010).